Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Genentech
Sort By
Newest First
1 / 1
1 / 1
Approval
Genentech Receives Additional Approval for Tecentriq
Emilie Branch
Pharma's Almanac
PAO-M12-18-NI-011
Dec 11, 2018
FDA Approval
Genentech Receives FDA Approval for Flu Medicine
David Alvaro, Ph.D.
Pharma's Almanac
PAO-M11-18-NI-001
Nov 05, 2018
Phase II Results
Promising Phase 2 Results for Eye Implant from Genentech
Nice Insight
PAO-M08-18-NI-003
Jul 31, 2018
Study Results
Phase III IMpower130 Study Showed Genentech’s TECENTRIQ (Atezolizumab) Plus Chemotherapy (Carboplatin and ABRAXANE) Helped Against Lung Cancer
Genentech
PR-M05-18-NI-116
May 31, 2018
Clinical Trials
Genentech Provides Update on Phase III Study of TECENTRIQ (Atezolizumab) and COTELLIC (Cobimetinib)
Genentech
PR-M05-18-NI-048
May 14, 2018
FDA Approval
Advanced Follicular Lymphoma Treatment Approved
Nice Insight
PAO-M11-17-NI-048
Nov 28, 2017
Biosimilar
FDA Approves First Biosimilar Treatment for Multiple Cancers
Emilie Branch
Pharma's Almanac
PAO-M09-17-NI-030
Sep 26, 2017
